Optimization ofgestosis prophylactics by correctionsepidermal and transforming growthfactors in earlyterms of pregnancyin women withthe risk of interruptionof pregnancy

Abstract

This study focuses on the clinical value of transforming growth factor-β (TGF-β2) and epidermal growth factor (EGF) in the maternal serum in earlier periods of pregnancy in order to set up groups at risk for the development of pregnancy complications.